IL-21-dependent expansion of memory-like NK cells enhances protective immune responses against Mycobacterium tuberculosis

Mucosal Immunology

Volumn 10, Issue 4, 2017, Pages 1031-1042

  Venkatasubramanian, S ^a   Cheekatla, S ^a   Paidipally, P ^a   Tripathi, D ^a   Welch, E ^a   Tvinnereim, A R ^a   Nurieva, R ^b   Vankayalapati, R ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD161 ANTIGEN; CD27 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 21; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; SMALL INTERFERING RNA; BLOCKING ANTIBODY; INTERLEUKIN DERIVATIVE;

ADOPTIVE TRANSFER; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; CELL EXPANSION; CELL ISOLATION; CELL PROLIFERATION; CELL PROTECTION; CELLULAR IMMUNITY; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; GENE DELETION; HUMAN; IMMUNE RESPONSE; INFECTION PREVENTION; LATENT TUBERCULOSIS; MACROPHAGE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; ADOLESCENT; ANIMAL; C57BL MOUSE; DISEASE MODEL; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INNATE IMMUNITY; KNOCKOUT MOUSE; MALE; METABOLISM; MIDDLE AGED; MYCOBACTERIUM BOVIS; VACCINATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIBODIES, BLOCKING; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; INTERLEUKINS; KILLER CELLS, NATURAL; LATENT TUBERCULOSIS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; RNA, SMALL INTERFERING; VACCINATION; YOUNG ADULT;

EID: 85020907046     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2016.105     Document Type: Article

References (50)

1. Zumla, A. et al. The WHO 2014 global tuberculosis report-further to go. Lancet Glob. Health 3, e10-e12 (2015).
2. Manabe, Y. C. & Bishai, W. R. Latent Mycobacterium tuberculosispersistence, patience, and winning by waiting. Nat. Med. 6, 1327-1329 (2000).
3. Flynn, J. L. &Chan, J. Immunology of tuberculosis. Annu. Rev. Immunol. 19, 93-129 (2001).
4. Flynn, J. L. et al. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178, 2249-2254 (1993).
5. Tay, C. H., Szomolanyi-Tsuda, E. &Welsh, R. M. Control of infections by NK cells. Curr. Top. Microbiol. Immunol. 230, 193-220 (1998).
6. Vankayalapati, R. et al. Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J. Immunol. 175, 4611-4617 (2005).
7. Vankayalapati, R. et al. NK cells regulate CD8 T cell effector function in response to an intracellular pathogen. J. Immunol. 172, 130-137 (2004).
8. Roy, S. et al. NK cells lyse T regulatory cells that expand in response to an intracellular pathogen. J. Immunol. 180, 1729-1736 (2008).
9. Dhiman, R. et al. NK1. 1 cells and IL-22 regulate vaccine-induced protective immunity against challenge with Mycobacterium tuberculosis. J. Immunol. 189, 897-905 (2012).
10. Marcenaro, E., Ferranti, B., Falco, M., Moretta, L. &Moretta, A. Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC. Int. Immunol. 20, 1155-1167 (2008).
11. Schierloh, P. et al. Increased susceptibility to apoptosis of CD56dimCD16 NK cells induces the enrichment of IFN-gammaproducing CD56bright cells in tuberculous pleurisy. J. Immunol. 175, 6852-6860 (2005).
12. Paust, S. et al. Critical role for the chemokine receptor CXCR6 in NK cellmediated antigen-specific memory of haptens and viruses. Nat Immunol 11, 1127-1135 (2010).
13. Sun, J. C., Lopez-Verges, S., Kim, C. C., DeRisi, J. L. & Lanier, L. L. NK cells and immune 'memory'. J. Immunol. 186, 1891-1897 (2011).
14. Lopez-Vergè s, S. et al. Expansion of a unique CD57NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl Acad. Sci. USA 108, 14725-14732 (2011).
15. Sun, J. C. et al. Proinflammatory cytokine signaling required for the generation of natural killer cellmemory. J. Exp. Med. 209, 947-954 (2012).
16. Yokoyama, W. M., Kim, S. & French, A. R. The dynamic life of natural killer cells. Annu. Rev. Immunol. 22, 405-429 (2004).
17. Shimizu, K. & Fujii, S. DCtherapy induces long-term NKreactivity to tumors via host DC. Eur. J. Immunol. 39, 457-468 (2009).
18. Jamieson, A. M., Isnard, P., Dorfman, J. R., Coles, M. C. & Raulet, D. H. Turnover and proliferation of NK cells in steady state and lymphopenic conditions. J. Immunol. 172, 864-870 (2004).
19. Prlic, M., Blazar, B. R., Farrar, M. A. & Jameson, S. C. In vivo survival and homeostatic proliferation of natural killer cells. J. Exp. Med. 197, 967-976 (2003).
20. Sun, J. C., Beilke, J. N., Bezman, N. A. & Lanier, L. L. Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection. J. Exp. Med. 208, 357-368 (2011).
21. O'Leary, J. G., Goodarzi, M., Drayton, D. L. & Andrian, U. H. von Tcell-andB cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 7, 507-516 (2006).
22. Cooper, M. A. et al. Cytokine-induced memory-like natural killer cells. Proc. Natl Acad. Sci. USA 106, 1915-1919 (2009).
23. Fu, X. et al. Human natural killer cells expressing the memory-associated marker CD45RO from tuberculous pleurisy respond more strongly and rapidly than CD45RO-natural killer cells following stimulation with interleukin-12. Immunology 134, 41-49 (2011).
24. Fu, X., Yang, B., Lao, S., Fan, Y. & Wu, C. Human memory-like NK cells migrating to tuberculous pleural fluid via IP-10/CXCR3 and SDF-1/CXCR4 axis produce IFN-g in response to Bacille Calmette Guerin. Clin. Immunol. 148, 113-123 (2013).
25. Kelly, M. N. et al. Memory CD4 T cells are required for optimal NK cell effector functions against the opportunistic fungal pathogen Pneumocystis murina. J. Immunol. 190, 285-295 (2013).
26. Bihl, F. et al. Primed antigen-specific CD4 Tcells are required for NK cell activation in vivo upon Leishmania major infection. J. Immunol. 185, 2174-2181 (2010).
27. Leong, J. W. et al. Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells. Biol. BloodMarrow Transplant 20, 463-473 (2014).
28. Shimizu, K., Asakura, M. & Fujii, S. Prolonged antitumor NK cell reactivity elicited by CXCL10-expressing dendritic cells licensed by CD40L CD4 memory T cells. J. Immunol. 186, 5927-5937 (2011).
29. McCall, M. B. B. et al. Memory-like IFN-g response by NK cells following malaria infection reveals the crucial role of T cells in NK cell activation by P. falciparum. Eur. J. Immunol. 40, 3472-3477 (2010).
30. Parrish-Novak, J. et al. Interleukin 21 and its receptor are involved inNKcell expansion and regulation of lymphocyte function. Nature 408, 57-63 (2000).
31. Habib, T., Nelson, A. & Kaushansky, K. IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses. J. Allergy Clin. Immunol. 112, 1033-1045 (2003).
32. Parrish-Novak, J., Foster, D. C., Holly, R. D. & Clegg, C. H. Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses. J. Leukoc. Biol. 72, 856-863 (2002).
33. Davis, I. D. et al. Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trial. Clin. Cancer Res. 15, 2123-2129 (2009).
34. Johnson, L. D. S. & Jameson, S. C. Immunology. A chronic need for IL-21. Science 324, 1525-1526 (2009).
35. Iannello, A. et al. IL-21 enhances NK cell functions and survival in healthy and HIV-infected patients with minimal stimulation of viral replication. J. Leukoc. Biol. 87, 857-867 (2010).
36. Strbo, N. et al. IL-21 augments natural killer effector functions in chronically HIV-infected individuals. AIDS 22, 1551-1560 (2008).
37. Derrick, S. C., Kolibab, K., Yang, A. & Morris, S. L. Intranasal administration of Mycobacterium bovis BCG induces superior protection against aerosol infection with Mycobacterium tuberculosis in mice. Clin. Vaccine Immunol 21, 1443-1451 (2014).
38. Dou, J. et al. Protection against Mycobacterium tuberculosis challenge in mice byDNAvaccine Ag85A-ESAT-6-IL-21 priming andBCGboosting. Int. J. Immunogenet. 39, 183-190 (2012).
39. Yu, F. et al. Nanoparticle-based adjuvant for enhanced protective efficacy ofDNAvaccine Ag85A-ESAT-6-IL-21 against Mycobacterium tuberculosis infection. Nanomedicine 8, 1337-1344 (2012).
40. Beverley, P. C. L. et al. A novel murine cytomegalovirus vaccine vector protects against Mycobacterium tuberculosis. J. Immunol. 193, 2306-2316 (2014).
41. Chiesa, M. Della et al. Human NK cell response to pathogens. Semin. Immunol. 26, 152-160 (2014).
42. Hart, O. M., Athie-Morales, V., O'Connor, G. M. & Gardiner, C. M. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production. J. Immunol. 175, 1636-1642 (2005).
43. Sivori, S. et al. A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2. Blood 116, 1637-1647 (2010).
44. Hendriks, J. et al. CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 1, 433-440 (2000).
45. Watt, S. V., Andrews, D. M., Takeda, K., Smyth, M. J. & Hayakawa, Y. IFN-gamma-dependent recruitment of mature CD27(high) NK cells to lymph nodes primed by dendritic cells. J. Immunol. 181, 5323-5330 (2008).
46. Brady, J. et al. The interactions of multiple cytokines control NK cell maturation. J. Immunol. 185, 6679-6688 (2010).
47. Marquardt, N., Wilk, E., Pokoyski, C., Schmidt, R. E. & Jacobs, R. Murine CXCR3CD27bright NK cells resemble the human CD56bright NK-cell population. Eur. J. Immunol. 40, 1428-1439 (2010).
48. Colvenaer, V. De. et al. CD27-deficient mice show normal NK-cell differentiation but impaired function upon stimulation. Immunol. Cell Biol. 89, 803-811 (2011).
49. Venkatasubramanian, S. et al. A rho GDP dissociation inhibitor produced by apoptotic T-cells inhibits growth of Mycobacterium tuberculosis. PLoS Pathog. 11, e1004617 (2015).
50. Zhang, X., Goncalves, R. &Mosser, D. M. The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. Chapter 14, Unit 14. 1 (2008).